SEC Form SC 13G/A filed by Surgery Partners Inc. (Amendment)
$SGRY
Hospital/Nursing Management
Health Care
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/16/2024 | $30.00 | Buy | BofA Securities |
| 10/14/2024 | $38.00 | Buy | UBS |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 6/28/2024 | $31.00 | Outperform | Macquarie |
| 3/6/2024 | $35.00 | Equal Weight | Barclays |
| 11/14/2023 | $39.00 → $35.00 | Market Perform → Outperform | TD Cowen |
| 6/2/2023 | $42.00 → $45.00 | Neutral → Buy | BofA Securities |
| 5/12/2023 | $48.00 | Buy | Mizuho |
BRENTWOOD, Tenn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that Dr. Laura L. Forese has been appointed to serve as an independent director on its Board of Directors. Dr. Forese's appointment, which is effective January 10, 2025, will increase the size of Surgery Partners' Board to eleven members. Dr. Forese joins the Surgery Partners Board with extensive healthcare experience. Her career in healthcare administration spans over 40 years, most recently serving as an executive vice president and chief operating officer for New York-Presbyterian, one of the nation's most comprehensive, integrated academic heal
PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,
PLANTATION, Fla., Aug. 12, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") provided a business update and announced the termination of employment of its Chief Financial Officer, William Larkin and the appointment of David Kretschmer as Interim Chief Financial Officer, effective today. The Company has implemented a transformation program with initiatives focused on its operations, growth, and capital. These initiatives are intended to support the Company's objectives with respect to patient access and experience, customer and partner engagement, financial sustainability, and employee well-being. The Company is receiving support from a globally recognized tr
BofA Securities initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $30.00
UBS initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $38.00
KeyBanc Capital Markets initiated coverage of Surgery Partners with a rating of Sector Weight
BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights(All comparisons are year-over-year unless otherwise noted) Revenue increased 8.2% for the first quarter Same-facility revenues increased 5.2% for the first quarterSame-facility cases increased 6.5% for the first quarter Net loss attributable to Surgery Partners, Inc. was $37.7 million for the first quarter Adjusted EBITDA increased 6.6% to $103.9 million for the first quarter 2025 Guidan
BRENTWOOD, Tenn., April 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2025 results before the market opens on Monday, May 12, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 26, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13752904 Interested investor
BRENTWOOD, Tenn., March 03, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 17.5% for the fourth quarter and 13.5% for the full year Same-facility revenues increased 5.6% for the fourth quarter and 8.0% for the full yearSame-facility cases increased 5.1% for the fourth quarter and 3.9% for the full year Net
BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights(All comparisons are year-over-year unless otherwise noted) Revenue increased 8.2% for the first quarter Same-facility revenues increased 5.2% for the first quarterSame-facility cases increased 6.5% for the first quarter Net loss attributable to Surgery Partners, Inc. was $37.7 million for the first quarter Adjusted EBITDA increased 6.6% to $103.9 million for the first quarter 2025 Guidan
BRENTWOOD, Tenn., April 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2025 results before the market opens on Monday, May 12, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 26, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13752904 Interested investor
BRENTWOOD, Tenn., March 03, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 17.5% for the fourth quarter and 13.5% for the full year Same-facility revenues increased 5.6% for the fourth quarter and 8.0% for the full yearSame-facility cases increased 5.1% for the fourth quarter and 3.9% for the full year Net
SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
SCHEDULE 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
10-Q - Surgery Partners, Inc. (0001638833) (Filer)
SCHEDULE 13G - Surgery Partners, Inc. (0001638833) (Subject)